Drug Companies Decline to Collaborate

+ See all authors and affiliations

Science  05 Dec 1997:
Vol. 278, Issue 5344, pp. 1704
DOI: 10.1126/science.278.5344.1704a

You are currently viewing the summary.

View Full Text


A group of leading pharmaceutical companies has shot down a proposal for a $180 million joint project to develop new treatments for the world's most threatening tropical diseases, particularly malaria. A group of public and private organizations put the proposal to the drug companies last month, and earlier confidential discussions were thought to be going well. But industry leaders who met in Switzerland last month decided that there are too many uncertainties and potential commercial conflicts to go ahead.